CN101032475A - 一种卡莫司汀的药用组合物、制备方法及用途 - Google Patents
一种卡莫司汀的药用组合物、制备方法及用途 Download PDFInfo
- Publication number
- CN101032475A CN101032475A CNA200710065089XA CN200710065089A CN101032475A CN 101032475 A CN101032475 A CN 101032475A CN A200710065089X A CNA200710065089X A CN A200710065089XA CN 200710065089 A CN200710065089 A CN 200710065089A CN 101032475 A CN101032475 A CN 101032475A
- Authority
- CN
- China
- Prior art keywords
- acid
- pharmaceutical composition
- carmustine
- salt
- injection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (25)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200710065089XA CN100544710C (zh) | 2007-04-03 | 2007-04-03 | 一种卡莫司汀的药用组合物、制备方法及用途 |
PCT/CN2008/000680 WO2008119260A1 (fr) | 2007-04-03 | 2008-04-03 | Composition médicinale de carmustine, procédé de préparation et application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200710065089XA CN100544710C (zh) | 2007-04-03 | 2007-04-03 | 一种卡莫司汀的药用组合物、制备方法及用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101032475A true CN101032475A (zh) | 2007-09-12 |
CN100544710C CN100544710C (zh) | 2009-09-30 |
Family
ID=38729342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200710065089XA Active CN100544710C (zh) | 2007-04-03 | 2007-04-03 | 一种卡莫司汀的药用组合物、制备方法及用途 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN100544710C (zh) |
WO (1) | WO2008119260A1 (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008119260A1 (fr) * | 2007-04-03 | 2008-10-09 | Beijing Century Biocom Pharmaceutical Technology Co., Ltd. | Composition médicinale de carmustine, procédé de préparation et application |
CN102579416A (zh) * | 2012-02-24 | 2012-07-18 | 于龙川 | 卡莫司汀的新用途 |
CN103610670A (zh) * | 2013-11-04 | 2014-03-05 | 鲁东大学 | 卡莫司汀在制备治疗淋巴瘤的药物中的应用 |
CN105616342A (zh) * | 2014-10-28 | 2016-06-01 | 北京世纪博康医药科技有限公司 | 甘草醇的药用组合物、制备方法及用途 |
CN105616360A (zh) * | 2014-10-28 | 2016-06-01 | 北京世纪博康医药科技有限公司 | 一种甘草醇的药用组合物、制备方法及用途 |
JP2017533950A (ja) * | 2014-11-14 | 2017-11-16 | ナビンタ トゥー エルエルシー | カルムスチン医薬組成物 |
CN110638765A (zh) * | 2019-11-08 | 2020-01-03 | 江苏食品药品职业技术学院 | 一种卡莫司汀冻干工艺 |
WO2019094819A3 (en) * | 2017-11-09 | 2020-03-26 | Abon Pharmaceuticals, Llc | Intravenous delivery systems for chemotherapy drugs |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20210322304A1 (en) * | 2018-09-05 | 2021-10-21 | Emcure Pharmaceuticals Ltd. | Stable ready-to-use carmustine pharmaceutical composition |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1198930A (zh) * | 1998-04-30 | 1998-11-18 | 大连市医药科学研究所 | 卡氮芥粉针剂及制备方法 |
CN1520808A (zh) * | 2003-02-09 | 2004-08-18 | 谷松兰 | 卡莫司汀前体脂质体粉针制剂及制备方法 |
CN1270779C (zh) * | 2004-05-13 | 2006-08-23 | 严家定 | 抗冻增溶抗氧化药物保护剂及其制备方法 |
CN1887265A (zh) * | 2006-07-25 | 2007-01-03 | 济南帅华医药科技有限公司 | 一种抗癌缓释剂 |
CN100544710C (zh) * | 2007-04-03 | 2009-09-30 | 北京世纪博康医药科技有限公司 | 一种卡莫司汀的药用组合物、制备方法及用途 |
-
2007
- 2007-04-03 CN CNB200710065089XA patent/CN100544710C/zh active Active
-
2008
- 2008-04-03 WO PCT/CN2008/000680 patent/WO2008119260A1/zh active Application Filing
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008119260A1 (fr) * | 2007-04-03 | 2008-10-09 | Beijing Century Biocom Pharmaceutical Technology Co., Ltd. | Composition médicinale de carmustine, procédé de préparation et application |
CN102579416A (zh) * | 2012-02-24 | 2012-07-18 | 于龙川 | 卡莫司汀的新用途 |
CN102579416B (zh) * | 2012-02-24 | 2013-10-30 | 于龙川 | 卡莫司汀在制备预防和/或治疗精神活性物质的依赖与复吸的药物中的应用 |
CN103610670A (zh) * | 2013-11-04 | 2014-03-05 | 鲁东大学 | 卡莫司汀在制备治疗淋巴瘤的药物中的应用 |
CN105616342A (zh) * | 2014-10-28 | 2016-06-01 | 北京世纪博康医药科技有限公司 | 甘草醇的药用组合物、制备方法及用途 |
CN105616360A (zh) * | 2014-10-28 | 2016-06-01 | 北京世纪博康医药科技有限公司 | 一种甘草醇的药用组合物、制备方法及用途 |
JP2017533950A (ja) * | 2014-11-14 | 2017-11-16 | ナビンタ トゥー エルエルシー | カルムスチン医薬組成物 |
WO2019094819A3 (en) * | 2017-11-09 | 2020-03-26 | Abon Pharmaceuticals, Llc | Intravenous delivery systems for chemotherapy drugs |
CN110638765A (zh) * | 2019-11-08 | 2020-01-03 | 江苏食品药品职业技术学院 | 一种卡莫司汀冻干工艺 |
Also Published As
Publication number | Publication date |
---|---|
CN100544710C (zh) | 2009-09-30 |
WO2008119260A1 (fr) | 2008-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101032475A (zh) | 一种卡莫司汀的药用组合物、制备方法及用途 | |
CN1429101A (zh) | 用于肠胃外给药的稳定水性混悬液 | |
CN100339078C (zh) | 固体口服剂型药物 | |
CN1829504A (zh) | 氨基酸组合物及补液 | |
CN101057846A (zh) | 注射用兰索拉唑及其制备方法 | |
CN1895239A (zh) | 一种姜黄素制剂及其制备方法 | |
CN1864684A (zh) | 多索茶碱冻干粉针注射剂及其制备方法 | |
CN101066260A (zh) | 一种辅酶q10乳剂及其冻干乳剂及制备方法 | |
CN1843327A (zh) | 一种稳定的含有多种维生素的冻干制剂及其制备方法 | |
CN1954808A (zh) | 高剂量盐酸氨溴索冻干制剂及制备方法 | |
CN1823789A (zh) | 谷维素组合物及其制备方法 | |
CN100345589C (zh) | 一种肠内要素营养制剂 | |
CN1128955A (zh) | 经皮吸收制剂 | |
CN1313086C (zh) | 一种注射用细辛脑制剂及制备方法 | |
CN1709248A (zh) | 一种兰索拉唑冻干粉针剂及其制备方法 | |
CN1092959C (zh) | 包含噻加宾或其药学上可接受的盐的药物组合物和其制备方法 | |
CN1265798C (zh) | 含有藻酸盐的药物组合物 | |
CN1915219A (zh) | 稳定化的脂质体 | |
CN1870995A (zh) | 使用埃坡霉素的癌症治疗 | |
CN1226999C (zh) | 适于胃肠外给药的增溶过的药物组合物 | |
CN101036642A (zh) | 银杏内酯b纳米脂质体药物及其制备方法 | |
CN101062049A (zh) | 一种替尼泊苷的药用组合物、制备方法及用途 | |
CN1784237A (zh) | 含有甲基维生素b12的冻干制剂及其制备方法 | |
CN1732913A (zh) | 一种稳定性好的棓丙酯注射液及其制备方法 | |
CN1700906A (zh) | 稳定的无菌过滤性脂质体包封的紫杉烷和其他抗肿瘤药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: MUDANJIANG HENGYUAN PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: BEIJING SHIJI BOKANG PHARMACEUTICAL SCI. + TECH. CO., LTD. Effective date: 20120321 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Yajun Inventor before: Hao Shouzhu |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100070 FENGTAI, BEIJING TO: 157009 MUDANJIANG, HEILONGJIANG PROVINCE Free format text: CORRECT: INVENTOR; FROM: HAO SHOUZHU TO: LI YAJUN |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120321 Address after: 157009 No. 94, Daqing Road, Mudanjiang, Heilongjiang Patentee after: MUDANJIANG HENGYUAN PHARMACEUTICAL CO., LTD. Address before: 100070 Beijing City, Fengtai District science and Technology Park of Fengtai Haiying Road No. 9, building 3 203 Jintang Patentee before: Beijing Shiji Bokang Pharmaceutical Sci. & Tech. Co., Ltd. |